|
|
Volumn 406, Issue 3, 2014, Pages 923-927
|
|
Development and validation of a LC-MS/MS method for d-cycloserine determination in human plasma for bioequivalence study
a
|
|
Author keywords
Cycloserine; HILIC MS MS; Method validation; Solid phase extraction
|
|
Indexed keywords
CHROMATOGRAPHIC SEPARATIONS;
CYCLOSERINE;
EUROPEAN MEDICINES AGENCIES;
HILIC-MS/MS;
METHOD VALIDATIONS;
SOLID-PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
TRIPLE-QUADRUPOLE MASS SPECTROMETER;
CARBOXYLIC ACIDS;
COMPUTERIZED TOMOGRAPHY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HIGH PRESSURE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PHASE SEPARATION;
PLASMA (HUMAN);
PYRIDINE;
EXTRACTION;
CYCLOSERINE;
TUBERCULOSTATIC AGENT;
ARTICLE;
BLOOD;
BLOOD ANALYSIS;
DRUG STABILITY;
HUMAN;
LIMIT OF DETECTION;
LIQUID CHROMATOGRAPHY;
METHODOLOGY;
REPRODUCIBILITY;
STANDARD;
TANDEM MASS SPECTROMETRY;
THERAPEUTIC EQUIVALENCE;
VALIDATION STUDY;
ANTIBIOTICS, ANTITUBERCULAR;
BLOOD CHEMICAL ANALYSIS;
CHROMATOGRAPHY, LIQUID;
CYCLOSERINE;
DRUG STABILITY;
HUMANS;
LIMIT OF DETECTION;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
TANDEM MASS SPECTROMETRY;
THERAPEUTIC EQUIVALENCY;
|
|
EID: 84893378370
PISSN: 16182642
EISSN: 16182650
Source Type: Journal
DOI: 10.1007/s00216-013-7521-x Document Type: Article |
|
Times cited : (15)
|
|
References (5)
|
